Press Releases Year None202220212020201920182017 Atreca Appoints Stephen Gould, Ph.D. as Chief Scientific Officer June 16, 2022 PDF Version READ MORE Atreca Announces Corporate Reorganization to Extend Cash Runway June 1, 2022 PDF Version READ MORE Atreca to Present at Upcoming Investor Conferences May 19, 2022 PDF Version READ MORE Atreca Reports First Quarter 2022 Financial Results and Recent Corporate Developments May 11, 2022 PDF Version READ MORE Atreca Announces Publication in PNAS: “Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101” May 4, 2022 PDF Version READ MORE Atreca to Present at Upcoming Virtual Investor Conferences April 8, 2022 PDF Version READ MORE Atreca Announces Expansion of Preclinical Pipeline April 5, 2022 PDF Version READ MORE Atreca to Host Virtual R&D Day on Tuesday, April 5, 2022 March 23, 2022 PDF Version READ MORE Atreca to Participate in Cowen 42nd Annual Healthcare Conference March 4, 2022 PDF Version READ MORE Atreca Reports Fourth Quarter and Full-Year 2021 Financial Results and ATRC-101 Data Update March 3, 2022 PDF Version READ MORE Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 12
